These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 34090396)

  • 1. Covid-19 and non-communicable diseases: evidence from a systematic literature review.
    Nikoloski Z; Alqunaibet AM; Alfawaz RA; Almudarra SS; Herbst CH; El-Saharty S; Alsukait R; Algwizani A
    BMC Public Health; 2021 Jun; 21(1):1068. PubMed ID: 34090396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19.
    Shibata S; Arima H; Asayama K; Hoshide S; Ichihara A; Ishimitsu T; Kario K; Kishi T; Mogi M; Nishiyama A; Ohishi M; Ohkubo T; Tamura K; Tanaka M; Yamamoto E; Yamamoto K; Itoh H
    Hypertens Res; 2020 Oct; 43(10):1028-1046. PubMed ID: 32737423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality from respiratory infections and chronic non-communicable diseases before the COVID-19 pandemic in Cali, Colombia.
    Bravo LE; Collazos P; Grillo Ardila EK; García LS; Millan E; Mera P; Holguín J
    Colomb Med (Cali); 2020 Jun; 51(2):e4270. PubMed ID: 33012885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of non-communicable diseases among Syrian refugees in Syria's neighbouring host countries: a systematic review and meta-analysis.
    Al-Oraibi A; Hassan O; Chattopadhyay K; Nellums LB
    Public Health; 2022 Apr; 205():139-149. PubMed ID: 35279542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineating clinical characteristics and comorbidities among 206 COVID-19 deceased patients in India: Emerging significance of renin angiotensin system derangement.
    Majeed J; Ajmera P; Goyal RK
    Diabetes Res Clin Pract; 2020 Sep; 167():108349. PubMed ID: 32712124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covid-19 and non-communicable diseases (NCDs) in Africa: a narrative review.
    Olanrewaju YA; Oladunni AA; David KB; Babatunde YO; Damilola IA; Adedeji O; Ahamefula CC
    Afr Health Sci; 2023 Sep; 23(3):412-421. PubMed ID: 38357149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal health and non-communicable disease prevention: An investment case for the post COVID-19 world and need for better health economic data.
    Kapur A; Hod M
    Int J Gynaecol Obstet; 2020 Aug; 150(2):151-158. PubMed ID: 32401348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis.
    Sadria M; Layton AT
    PLoS Comput Biol; 2020 Oct; 16(10):e1008235. PubMed ID: 33031368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic non-communicable diseases in the epidemic (COVID-19): Investigation of risk factors, control and care.
    Aleebrahim-Dehkordi E; Deravi N; Reyhanian A; Saberianpour S; Mokhtari M; Hasanpour-Dehkordi A
    Przegl Epidemiol; 2020; 74(3):449-456. PubMed ID: 33570342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Old Age and Comorbidity
    Goswami GG; Mahapatro M; Ali ARMM; Rahman R
    Front Public Health; 2021; 9():736347. PubMed ID: 34869152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: Are Non-Communicable Diseases Risk Factors for Its Severity?
    Bello B; Useh U
    Am J Health Promot; 2021 Jun; 35(5):720-729. PubMed ID: 33576237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of COVID-19 on the lives of Canadians with and without non-communicable chronic diseases: results from the iCARE Study.
    Deslauriers F; Gosselin-Boucher V; Léger C; Vieira AM; Bacon SL; Lavoie KL
    BMC Public Health; 2023 Oct; 23(1):2106. PubMed ID: 37884921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to healthcare services for people with non-communicable diseases during the COVID-19 pandemic in Ibadan, Nigeria: a qualitative study.
    Ojewale LY; Mukumbang FC
    BMC Health Serv Res; 2023 Nov; 23(1):1231. PubMed ID: 37946244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.
    Rico-Mesa JS; White A; Anderson AS
    Curr Cardiol Rep; 2020 Apr; 22(5):31. PubMed ID: 32291526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Pandemic and Burden of Non-Communicable Diseases: An Ecological Study on Data of 185 Countries.
    Azarpazhooh MR; Morovatdar N; Avan A; Phan TG; Divani AA; Yassi N; Stranges S; Silver B; Biller J; Tokazebani Belasi M; Kazemi Neya S; Khorram B; Frydman A; Nilanont Y; Onorati E; Di Napoli M
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105089. PubMed ID: 32807484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of behavioural risk factors on communicable diseases: a systematic review of reviews.
    Wood S; Harrison SE; Judd N; Bellis MA; Hughes K; Jones A
    BMC Public Health; 2021 Nov; 21(1):2110. PubMed ID: 34789209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.
    Zawilska JB; Lagodzinski A; Berezinska M
    J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.